Press Release • Oct 13, 2026

Every Cure named Overall Winner of Newsweek’s AI Impact Awards

Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall winner of Newsweek’s inaugural AI Impact Awards.

Help bring the next treatment within reach.

Your support helps Every Cure identify and advance promising treatments for patients who still have limited options.

Donate

Keep Reading

Press Release • Oct 13

The New Yorker Profiled Our Work!

When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started to feel so tired that he could barely stand.

Press Release • Oct 13

Every Cure Receives $15M NIH Grant

Funding will directly accelerate our global drug mapping database, ranking 22,000 therapeutics against all human diseases.

Press Release • Jul 21

Updated NCCN Guidelines Elevate Repurposed Treatment to Preferred Option for Patients with Rosai-Dorfman Disease

Lenalidomide/dexamethasone (len/dex) is now recommended as a preferred treatment option for patients with Rosai-Dorfman Disease regardless of mutation status, potentially expanding access to an effective,